Immix Biopharma Inc (IMMX)

Immix Biopharma Inc (IMMX) 財務データ

損益計算書

四半期ごと

*すべての数値は百万単位です

期間終了日	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
期間の長さ	3 か月	3 か月	3 か月	3 か月	3 か月
Revenues	-	-	-	-	-
Operating Expenses	3.99% 5.5901	5.3759	4.5238	3.7207	2.5208
Operating Income/Loss	3.99% -5.5901	-5.3759	-4.5238	-3.7207	-2.5208
Nonoperating Income/Loss	0.2679	-	-	0.1288	0.0279
Income/Loss From Continuing Operations Before Tax	3.40% -5.3222	-5.1473	-4.3371	-3.5919	-2.4929
Income Tax Expense/Benefit	9.27% 0.00884	0.00809	0.00681	0.00635	0.00517
Income/Loss From Continuing Operations After Tax	3.41% -5.3311	-5.1554	-4.3439	-3.5982	-2.498
Net Income/Loss	3.41% -5.3311	-5.1554	-4.3439	-3.5982	-2.498
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	9.43% -0.0721	-0.0659	-0.0632	-	-
Basic Average Shares	1,484% 23.44	1.48	18.58	15.04	13.90
Diluted Average Shares	1,484% 23.44	1.48	18.58	15.04	-0.5706
Basic Earnings Per Share	8.33% -0.22	-0.24	-0.23	-0.24	-0.18
Diluted Earnings Per Share	8.33% -0.22	-0.24	-0.23	-0.24	-0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-